Related Experiment Video
Updated: Oct 7, 2025

Treatment Model for Young Patients with Psychogenic Erectile Dysfunction and Resultant Infertility
Published on: May 30, 2025
Testosterone replacement therapy and erectile dysfunction
Ifeanyi C Onyeji1, Raul I Clavijo2
1Department of Urology, University of California, Davis, Sacramento, CA, USA.
Testosterone (T) deficiency often co-occurs with erectile dysfunction (ED), complicating treatment. While T replacement shows some promise, optimal treatment strategies and consensus remain elusive.
Area of Science:
- Andrology
- Urology
- Endocrinology
Background:
- Testosterone (T) deficiency and erectile dysfunction (ED) are common, impairing quality of life.
- Understanding T's role in erectile function is crucial for effective treatment.
- Conflicting data exists on T replacement efficacy for ED.
Purpose of the Study:
- To review the mechanisms of T in erectile function.
- To analyze the efficacy of T replacement therapy for ED.
- To identify areas lacking consensus in managing co-occurring T deficiency and ED.
Main Methods:
- Review of existing literature on T and ED.
- Analysis of randomized controlled trial data.
- Examination of meta-analyses findings.
Main Results:
- T influences nitric oxide synthase and phosphodiesterase type 5 activity.
- Some T replacement therapies show positive but not always clinically meaningful results for ED.
- Meta-analyses suggest promising trends for T therapy in ED.
Conclusions:
- Consensus is lacking on optimal T thresholds for therapy initiation.
- Further research is needed on the timing and duration of T replacement and combination therapies for ED.
Related Concept Videos
Disorders of the Male Reproductive System
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
Testosterone: Functions and Regulation
Male Sexual Response: Erection & Ejaculation
The blood filling the erectile tissues compresses the veins, which helps to prevent blood from leaving...
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Infertility in Males
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment

